Literature DB >> 21528473

The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).

Krzysztof C Lewandowski1, Agata Cajdler-Łuba, Ireneusz Salata, Małgorzata Bieńkiewicz, Andrzej Lewiński.   

Abstract

INTRODUCTION: Polycystic ovary syndrome (PCOS) is characterised by increased frequency of hypothalamic GnRH pulses leading to a relative increase in LH synthesis by the pituitary. As GnRH stimulation can reveal a relative LH excess, we have endeavoured to assess whether GnRH test might be useful in the diagnosis of PCOS.
MATERIAL AND METHODS: The study involved 185 subjects: a PCOS group, n = 151, all with oligo- or amenorrhoea, aged (mean ± SD) 24.8 ± ± 5.4 years, BMI 24.5 ± 6.0 kg/m²; and regularly menstruating controls, n = 34, aged 26.6 ± 5.0 years, BMI 24.6 ± 5.5 kg/m². In 121 subjects with PCOS and in 32 controls, serum LH and FSH were measured before (0 minutes) and 30 and 60 minutes after GnRH stimulation (100 μg i.v.). Insulin resistance was assessed by HOMA and Insulin Resistance Index derived from glucose and insulin concentrations during 75 gram oral glucose tolerance test.
RESULTS: Women with PCOS had higher testosterone (p = 0.0002), androstendione (p = 0.0021), 17OH-progesterone (p < 0.0001) and were more insulin resistant. Raised concentrations of at least one androgen were, however, found only in 58.1% of women with PCOS. Baseline and stimulated LH concentrations were higher in PCOS (9.09 ± 5.56 vs 4.83 ± 1.71 IU/L, 35.48 ± 31.4 vs 16.30 ± 6.68 IU/L, 33.86 ± 31.8 vs 13.45 ± 5.2 IU/L, at 0, 30 and 60 mins post GnRH, respectively, p < 0.0001). There was no difference in baseline or stimulated FSH concentrations between groups. Relative increases of LH or FSH in comparison to respective baseline values were similar in both groups. There was, however, a marked increase in LH/FSH ratio in PCOS in comparison to controls (LH0 min/FSH(₀ min) 1.59 ± 0.95 vs 0.76 ± 0.2, LH(₃₀ min) /FSH(₃₀ min) 4.07 ± 3.0 vs 1.89 ± 0.79, LH(₆₀ min)/FSH(₆₀ min) 3.56 ± 2.58 vs 1.55 ± 0.63, p < 0.0001 at all time points). Further analysis revealed that LH30 min/FSH(₃₀ min) > 2.11 or LH(₆₀ min)/FSH(₆₀ min) > 1.72 had 78.3% and 87.5% sensitivity and 81.7% and 81.3% specificity for the diagnosis of PCOS, respectively.
CONCLUSIONS: Women with PCOS have higher baseline and GnRH-stimulated LH concentrations. GnRH stimulation results in an increase in LH/FSH ratio in women with PCOS. Therefore we postulate that this phenomenon might be potentially useful as an additional tool in the diagnosis of PCOS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528473

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  9 in total

1.  Quantitation of endogenous GnRH by validated nano-HPLC-HRMS method: a pilot study on ewe plasma.

Authors:  Federica Dal Bello; Claudio Medana; Enrica Mecarelli; Riccardo Aigotti; Alberto Asteggiano; Paolo Giacobini; Manon Chasles; Yves Tillet
Journal:  Anal Bioanal Chem       Date:  2022-09-05       Impact factor: 4.478

2.  Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.

Authors:  Anindya Dasgupta; Aparna Khan; Ushasi Banerjee; Mrinalkanti Ghosh; Mrinal Pal; Kanika M Chowdhury; Sayantan Dasgupta
Journal:  Indian J Clin Biochem       Date:  2012-09-14

3.  Characterization of embryonic stem cell model of polycystic ovary syndrome.

Authors:  Yue Zhang; Yun-Shan Zhang; Feng-Xia Xue
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-25       Impact factor: 2.416

4.  The female athlete triad.

Authors:  Taraneh Gharib Nazem; Kathryn E Ackerman
Journal:  Sports Health       Date:  2012-07       Impact factor: 3.843

5.  Hormonal and metabolic effects of polyunsaturated fatty acid (omega-3) on polycystic ovary syndrome induced rats under diet.

Authors:  Elaheh Ouladsahebmadarek; Arash Khaki; Sharareh Khanahmadi; Hamidreza Ahmadi Ashtiani; Pooya Paknejad; Mohammad Reza Ayubi
Journal:  Iran J Basic Med Sci       Date:  2014-02       Impact factor: 2.699

Review 6.  Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.

Authors:  Eng-Loon Tng; Jeanne May May Tan
Journal:  J Endocr Soc       Date:  2020-11-05

7.  Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology.

Authors:  Marlene Hager; Johannes Ott; Julian Marschalek; Marie-Louise Marschalek; Clemens Kinsky; Rodrig Marculescu; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2022-07-04       Impact factor: 4.982

Review 8.  Endocrinology and physiology of pseudocyesis.

Authors:  Juan J Tarín; Carlos Hermenegildo; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2013-05-14       Impact factor: 5.211

9.  miR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1).

Authors:  Yungai Xiang; Yuxia Song; Yan Li; Dongmei Zhao; Liying Ma; Li Tan
Journal:  Med Sci Monit       Date:  2016-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.